Neural correlates of attentional bias for smoking cues: Modulation by variance in the dopamine transporter gene

Addiction Biology

Volumn 19, Issue 2, 2014, Pages 294-304

  Wetherill, Reagan R ^a   Jagannathan, Kanchana ^a   Lohoff, Falk W ^a   Ehrman, Ronald ^b   O'Brien, Charles P ^a   Childress, Anna Rose ^a   Franklin, Teresa R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Addiction; attentional bias; dopamine transporter; neuroimaging; smoking cues

Indexed keywords

DOPAMINE TRANSPORTER; SLC6A3 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ALLELE; AMYGDALOID NUCLEUS; ASSOCIATION; ATTENTION; BRAIN CIRCULATION; BRAIN CORTEX; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HIPPOCAMPUS; HUMAN; IMAGE PROCESSING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHOTOSTIMULATION; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY; REACTION TIME; RECURRENT DISEASE; SMOKING; STATISTICS AND NUMERICAL DATA; TANDEM REPEAT; YOUNG ADULT;

ADOLESCENT; ADULT; ALLELES; AMYGDALA; ATTENTION; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; CUES; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PHOTIC STIMULATION; POLYMORPHISM, GENETIC; REACTION TIME; RECURRENCE; SMOKING; TANDEM REPEAT SEQUENCES; YOUNG ADULT;

EID: 84894426659     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2012.00507.x     Document Type: Article

References (65)

1. Aguirre GK, Detre JA, Wang J, (2005) Perfusion fMRI for functional neuroimaging. Int Rev Neurobiol 66: 213-236.
2. Benowitz NL, (2009) Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol 49: 57-71.
3. Boakes R, ed. (1977) Performance on Learning to Associate a Stimulus with Positive Reinforcement. Hillsdale, NJ: Erlbaum.
4. Brandon TH, Drobes DJ, Unrod M, Heckman BW, Oliver JA, Roetzheim RC, Karver SB, Small BJ, (2011) Varenicline effects on craving, cue reactivity, and smoking reward. Psychopharmacology 218: 391-403.
5. Carter BL, Tiffany ST, (1999) Cue-reactivity and the future of addiction research. Addiction 94: 349-351.
6. Coe JW, Brooks PR, Vetelino MG, Wirtz MC, Arnold EP, Huang J, Sands SB, Davis TI, Lebel LA, Fox CB, Shrikhande A, Heym JH, Schaeffer E, Rollema H, Lu Y, Mansbach RS, Chambers LK, Rovetti CC, Schulz DW, Tingley FD 3rd, O'Neill BT, (2005) Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem 48: 3474-3477.
7. Culbertson CS, Bramen J, Cohen MS, London ED, Olmstead RE, Gan JJ, Costello MR, Shulenberger S, Mandelkern MA, Brody AL, (2011) Effect of bupropion treatment on brain activation induced by cigarette-related cues in smokers. Arch Gen Psychiatry 68: 505-515.
8. Detre JA, Leigh JS, Williams DS, Koretsky AP, (1992) Perfusion imaging. Magn Reson Med 23: 37-45.
9. Di Chiara G, (1999) Drug addiction as dopamine-dependent associative learning disorder. Eur J Pharmacol 375: 13-30.
10. Di Chiara G, Tanda G, Bassareo V, Pontieri F, Acquas E, Fenu S, Cadoni C, Carboni E, (1999) Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine. Ann N Y Acad Sci 877: 461-485.
11. Dolan RJ, (2007) The human amygdala and orbital prefrontal cortex in behavioural regulation. Philos Trans R Soc Lond B Biol Sci 362: 787-799.
12. Droungas A, Ehrman RN, Childress AR, O'Brien CP, (1995) Effect of smoking cues and cigarette availability on craving and smoking behavior. Addict Behav 20: 657-673.
13. Duvernoy HM, (1999) The Human Brain: Surface, Three-Dimensional Sectional Anatomy with Magnetic Resonance Imaging and Blood Supply, 2nd edn. New York City: Springer-Verlag Wien.
14. Ehrman RN, Robbins SJ, Bromwell MA, Lankford ME, Monterosso JR, O'Brien CP, (2002) Comparing attentional bias to smoking cues in current smokers, former smokers, and non-smokers using a dot-probe task. Drug Alcohol Depend 67: 185-191.
15. Fagerstrom KO, Schneider NG, (1989) Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med 12: 159-182.
16. Field M, Cox WM, (2008) Attentional bias in addictive behaviors: a review of its development, causes, and consequences. Drug Alcohol Depend 97: 1-20.
17. Field M, Munafo MR, Franken IH, (2009) A meta-analytic investigation of the relationship between attentional bias and subjective craving in substance abuse. Psychol Bull 135: 589-607.
18. Flagel SB, Akil H, Robinson TE, (2009) Individual differences in the attribution of incentive salience to reward-related cues: implications for addiction. Neuropharmacology 56 (Suppl 1): 139-148.
19. Flagel SB, Watson SJ, Robinson TE, Akil H, (2007) Individual differences in the propensity to approach signals vs goals promote different adaptations in the dopamine system of rats. Psychopharmacology (Berl) 191: 599-607.
20. Floyd TF, Ratcliffe SJ, Wang J, Resch B, Detre JA, (2003) Precision of the CASL-perfusion MRI technique for the measurement of cerebral blood flow in whole brain and vascular territories. J Magn Reson Imaging 18: 649-655.
21. Franken IH, (2003) Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches. Prog Neuropsychopharmacol Biol Psychiatry 27: 563-579.
22. Franklin TR, Ehrman R, Lynch KG, Harper D, Sciortino N, O'Brien CP, Childress AR, (2008) Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: a retrospective analysis. J Womens Health (Larchmt) 17: 287-292.
23. Franklin TR, Lohoff FW, Wang Z, Sciortino N, Harper D, Li Y, Jens W, Cruz J, Kampman K, Ehrman R, Berrettini W, Detre JA, O'Brien CP, Childress AR, (2009) DAT genotype modulates brain and behavioral responses elicited by cigarette cues. Neuropsychopharmacology 34: 717-728.
24. Franklin TR, Wang Z, Li Y, Suh JJ, Goldman M, Lohoff FW, Cruz J, Hazan R, Jens W, Detre JA, Berrettini W, O'Brien CP, Childress AR, (2011a) Dopamine transporter genotype modulation of neural responses to smoking cues: confirmation in a new cohort. Addict Biol 16: 308-322.
25. Franklin TR, Wang Z, Suh JJ, Hazan R, Cruz J, Li Y, Goldman M, Detre JA, O'Brien CP, Childress AR, (2011b) Effects of varenicline on smoking cue-triggered neural and craving responses. Arch Gen Psychiatry 68: 516-526.
26. Franklin TR, Wang Z, Wang J, Sciortino N, Harper D, Li Y, Ehrman R, Kampman K, O'Brien CP, Detre JA, Childress AR, (2007) Limbic activation to cigarette smoking cues independent of nicotine withdrawal: a perfusion fMRI study. Neuropsychopharmacology 32: 2301-2309.
27. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S, (2001) The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 1: 152-156.
28. Gottfried JA, O'Doherty J, Dolan RJ, (2003) Encoding predictive reward value in human amygdala and orbitofrontal cortex. Science 301: 1104-1107.
29. Hampton AN, Adolphs R, Tyszka MJ, O'Doherty JP, (2007) Contributions of the amygdala to reward expectancy and choice signals in human prefrontal cortex. Neuron 55: 545-555.
30. Hearst E, Jenkins H, (1974) Sign-Tracking: The Stimulus-Reinforcer Relation and Directed Action. Austin: Monograph of the Psychonomic Society.
31. Jaber M, Jones S, Giros B, Caron MG, (1997) The dopamine transporter: a crucial component regulating dopamine transmission. Mov Disord 12: 629-633.
32. Janes AC, Pizzagalli DA, Richardt S, deB Frederick B, Chuzi S, Pachas G, Culhane MA, Holmes AJ, Fava M, Evins AE, Kaufman MJ, (2010a) Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biol Psychiatry 67: 722-729.
33. Janes AC, Pizzagalli DA, Richardt S, Frederick Bde B, Holmes AJ, Sousa J, Fava M, Evins AE, Kaufman MJ, (2010b) Neural substrates of attentional bias for smoking-related cues: an FMRI study. Neuropsychopharmacology 35: 2339-2345.
34. Kanske P, Kotz SA, (2011) Emotion triggers executive attention: anterior cingulate cortex and amygdala responses to emotional words in a conflict task. Hum Brain Mapp 32: 198-208.
35. Lahiri DK, Nurnberger JI Jr, (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19: 5444.
36. Lang PJ, Bradley MM, Cuthbert BN, (1997) Motivated attention: affect, activation, and action. In:, Lang PJ, Simons RF, Balaban MT, eds. Attention and Orienting: Sensory and Motivational Processes, pp. 97-135. Mahwah, NJ: Erlbaum.
37. Lubman DI, Peters LA, Mogg K, Bradley BP, Deakin JF, (2000) Attentional bias for drug cues in opiate dependence. Psychol Med 30: 169-175.
38. Mai JK, Voss T, Paxinos G, (2008) Atlas of the Human Brain. New York: Elsevier Academic Press.
39. McClernon FJ, Hutchison KE, Rose JE, Kozink RV, (2007) DRD4 VNTR polymorphism is associated with transient fMRI-BOLD responses to smoking cues. Psychopharmacology 194: 433-441.
40. Mill J, Asherson P, Browes C, D'Souza U, Craig I, (2002) Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet 114: 975-979.
41. O'Brien CP, Childress AR, Ehrman R, Robbins SJ, (1998) Conditioning factors in drug abuse: can they explain compulsion? J Psychopharmacol 12: 15-22.
42. Okuyemi KS, Powell JN, Savage CR, Hall SB, Nollen N, Holsen LM, McClernon FJ, Ahluwalia JS, (2006) Enhanced cue-elicited brain activation in African American compared with Caucasian smokers: an fMRI study. Addict Biol 11: 97-106.
43. Phillips ML, Drevets WC, Rauch SL, Lane R, (2003) Neurobiology of emotion perception I: the neural basis of normal emotion perception. Biol Psychiatry 54: 504-514.
44. Robinson TE, Berridge KC, (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18: 247-291.
45. Robinson TE, Berridge KC, (2000) The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 95 (Suppl 2): S91-117.
46. Robinson TE, Flagel SB, (2009) Dissociating the predictive and incentive motivational properties of reward-related cues through the study of individual differences. Biol Psychiatry 65: 869-873.
47. Salzman CD, Fusi S, (2010) Emotion, cognition, and mental state representation in amygdala and prefrontal cortex. Annu Rev Neurosci 33: 173-202.
48. Saunders BT, Robinson TE, (2010) A cocaine cue acts as an incentive stimulus in some but not others: implications for addiction. Biol Psychiatry 67: 730-736.
49. Saunders BT, Robinson TE, (2011) Individual variation in the motivational properties of cocaine. Neuropsychopharmacology 36: 1668-1676.
50. Sheehan B, Lecrubier Y, Sheehan K, (1998) The Mini International Neuropsychiatric Interview (MINI): the development and validation of structured diagnostic interview for DSM-IV and ICD-10. J Clin Psychiatry 59: 22-33.
51. Siep N, Roefs A, Roebroeck A, Havermans R, Bonte ML, Jansen A, (2009) Hunger is the best spice: an fMRI study of the effects of attention, hunger and calorie content on food reward processing in the amygdala and orbitofrontal cortex. Behav Brain Res 198: 149-158.
52. Sinha R, (2009) Stress and addiction: a dynamic interplay of genes, environment, and drug intake. Biol Psychiatry 66: 100-101.
53. Sinha R, Li CS, (2007) Imaging stress- and cue-induced drug and alcohol craving: association with relapse and clinical implications. Drug Alcohol Rev 26: 25-31.
54. Small DM, Zatorre RJ, Dagher A, Evans AC, Jones-Gotman M, (2001) Changes in brain activity related to eating chocolate: from pleasure to aversion. Brain 124: 1720-1733.
55. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM, (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23 (Suppl 1): S208-S219.
56. Tomie A, Grimes KL, Pohorecky LA, (2008) Behavioral characteristics and neurobiological substrates shared by Pavlovian sign-tracking and drug abuse. Brain Res Rev 58: 121-135.
57. Townshend JM, Duka T, (2001) Attentional bias associated with alcohol cues: differences between heavy and occasional social drinkers. Psychopharmacology (Berl) 157: 67-74.
58. Vandenbergh DJ, Bennett CJ, Grant MD, Strasser AA, O'Connor R, Stauffer RL, Vogler GP, Kozlowski LT, (2002) Smoking status and the human dopamine transporter variable number of tandem repeats (VNTR) polymorphism: failure to replicate and finding that never-smokers may be different. Nicotine Tob Res 4: 333-340.
59. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR, (1992) Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14: 1104-1106.
60. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR, Jayne M, Ma Y, Wong C, (2006) Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 26: 6583-6588.
61. Wang Z, Aguirre GK, Rao H, Wang J, Fernandez-Seara MA, Childress AR, Detre JA, (2008) Empirical optimization of ASL data analysis using an ASL data processing toolbox: ASLtbx. Magn Reson Imaging 26: 261-269.
62. Waters AJ, Carter BL, Robinson JD, Wetter DW, Lam CY, Kerst W, Cinciripini PM, (2009) Attentional bias is associated with incentive-related physiological and subjective measures. Exp Clin Psychopharmacol 17: 247-257.
63. Weschler D, (1999) Wechsler Abbreviated Scale of Intelligence Manual. San Antonio, TX: Harcourt Brace & Company.
64. Wikler A, Pescor FT, (1967) Classical conditioning of a morphine abstinence phenomenon, reinforcement of opioid-drinking behavior and 'relapse' in morphine-addicted rats. Psychopharmacologia 10: 255-284.
65. Wu P, Wilson K, Dimoulas P, Mills EJ, (2006) Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health 6: 300-316.